Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced the presentation of information from insurance claims and survey databases highlighting the unmet need for targeted therapies to treat subpopulations at high risk of recurrence of Clostridium difficile infection (CDI). The research also presented the substantial mortality and frequent complications associated with CDI.

Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced the presentation of information from insurance claims and survey databases highlighting the unmet need for targeted therapies to treat subpopulations at high risk of recurrence of Clostridium difficile infection (CDI). The research also presented the substantial mortality and frequent complications associated with CDI. Investigator Erik R.

American Video Teleconferencing Corp. (AVOT.PK)

The global market for rare earths consumed 126,682 metric tons of materials in 2008 and an estimated 113,610 metric tons in 2009. This is expected to increase to 175,618 metric tons in 2014, for a compound annual growth rate (CAGR) of 9.1%.

Power3 Medical Products, Inc. (OTCBB:PWRM) released that company management believes Power3 is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.